Hemostatic procedures in gastric endoscopic submucosal exfoliation (ESD)

Not Applicable

Recruiting

• Conditions: All patients who underwent gastric ESD at our department during the eligible period

• Registration Number: JPRN-UMIN000052773
• Lead Sponsor: Hiroshima City North Medical Center Asa Citizens Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-11-13
• Last Update Posted: 22 January 2024
• Study Completion: 2024-12-31

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Not provided

Exclusion Criteria

Patients who did not give consent for clinical research.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary endpoint is the frequency of posterior hemorrhage. Secondary endpoints are the number of coagulation hemostasis at second-look endoscopy and the size of the ulcer base of the posttreatment ulcer at 1 and 2 months after ESD.